MYLK and hepatocellular carcinoma: MYLK has been reported to phosphorylate myosin light chains (MLC) and regulate the invasion and metastasis of HCC and some other malignancies, which were mainly focused on MYLK subtype smMYLK (108–130 kD) [31].